Find here all the news from the CBM and beyond
1 2 3 4 7
The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
The second edition, edited by Marc Boudvillain, has just been published
NMR studies show 16 metabolites discriminate symptomatic from presymptomatic stages in a Drosophila model of Huntington's disease. Potential biomarkers of the human disease?
CBM researchers in collaboration with INSERM U1195 (Kremlin-Bicêtre) have shown that the LINGO-1 receptor can form homo- and hetero-complexes with its homologs LINGO-2, LINGO-3 and LINGO-4 in the brain thus opening the way to new strategies to modulate their activity.
Researchers from CBM and the University of Michigan used a lanthanide, dysprosium, to generate pure white light with no variation in hue.
Scientists increasingly rely on software, but software is fragile. How long can we expect our software to remain usable? Only practice can tell.
Publication of an article by Jean-Marc Bonmatin and his collaborators from the Task Force on Systemic Pesticides on the impact of pesticides on health through food, and on alternative agronomic solutions
Solutions for the conservation and restoration of biodiversity
Researchers have created a predictive model based on the detection of changes in metabolite concentration resolved by ¹H high-resolution MAS NMR
The Achille Le Bel Grand Prize, awarded by the Société Chimique de France, rewards internationally recognized works.